{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:43:19Z","timestamp":1792233799646,"version":"4.4.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtct.2026.09.017","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:18:06Z","timestamp":1789024686000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cDisparities in Allogeneic Hematopoietic Stem Cell Transplantation among Acute Myeloid Leukemia Patients\u201d"],"prefix":"10.1016","author":[{"given":"Janani","family":"Gopalakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Bharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Prasanth","family":"Baalann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2026.09.017_bib0001","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jtct.2026.01.019","article-title":"Disparities in allogeneic hematopoietic stem cell transplantation among acute myeloid leukemia patients","volume":"32","author":"Kang","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.09.017_bib0002","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.21873\/anticanres.17784","article-title":"Exploring demographic, prognostic, and socioeconomic determinants of survival in lymphocyte-rich classical Hodgkin lymphoma: a National Cancer Database study","volume":"45","author":"Rafie","year":"2025","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.jtct.2026.09.017_bib0003","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/09710973251405550","article-title":"Examining egg donor rights in the Surrogacy (Regulation) Act, 2021 of India: a medico-legal study","volume":"47","author":"Chatterjee","year":"2025","journal-title":"J Indian Acad Forensic Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.017_bib0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/17474086.2025.2610282","article-title":"Improving transfusion access through improved policy: a call for a less fragmented blood supply","volume":"19","author":"Jacobs","year":"2025","journal-title":"Exp Rev Hematol"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.017_bib0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41409-025-02508-2","article-title":"Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55","volume":"60","author":"Oshima","year":"2025","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:57:15Z","timestamp":1792231035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726007220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":5,"alternative-id":["S2666636726007220"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.017","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cDisparities in Allogeneic Hematopoietic Stem Cell Transplantation among Acute Myeloid Leukemia Patients\u201d","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}